3

FORM 3 SUBMISSION

Company: Viridian Therapeutics, Inc.\DE
Filed: January 21, 2021
Period of Report: January 20, 2021
Accession Number: 0000899243-21-002779

View Document ↗ View on SEC.gov ↗